Glaucoma Associates of Texas
Dallas, Texas, 75231, United States
NCT Number: NCT01212861
The primary objective of this study is to evaluate the safety, efficacy, and performance of the Suprachoroidal Dissection Instrument in creating a fistula between Schlemm's canal and the suprachoroidal space in refractory, open angle glaucoma subjects.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Dallas, Texas, 75231, United States
The Suprachoroidal Dissection Instrument (SDI) is a manually operated surgical instrument designed for use within Schlemm's canal. The instrument can access Schlemm's canal through a small ab-externo dissection, allowing use in eyes with scarring due to previous surgery or trauma.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Suprachoroidal Dissection Instrument (SDI) is a manually operated, non-powered, re-usable ophthalmic surgical instrument. The SDI is designed to enter a surgically exposed Schlemm's canal and be advanced up to 90 degrees around the canal from the entry site.
Other names: SDI
Time frame: 12 months
iScience Interventional Corporation
Industry
Surgical Treatment of Refractory Open Angle Glaucoma - A Prospective, Open-Label, Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07082816
Eye Diseases, Glaucoma
Dothan, Alabama, United States
View Trial DetailsNCT06851546
Eye Diseases, Glaucoma
Rochester, Minnesota, United States
View Trial DetailsNCT04060758
Eye Diseases, Glaucoma
Castle Hill, New South Wales, Australia
View Trial DetailsNCT06441643
Eye Diseases, Glaucoma
Garden Grove, California, United States
View Trial Details